Gene: CSAG1
Official Full Name: chondrosarcoma associated gene 1provided by HGNC
Gene Summary: This gene encodes a member of a family of tumor antigens. The protein is expressed in chondrosarcomas, but may also be expressed in normal tissues such as testis. Alternative splicing of this gene results in two transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18521 | CSAG1 Knockout cell line (HeLa) | Human | CSAG1 | 1:3~1:6 | Negative | Online Inquiry |
KO18522 | CSAG1 Knockout cell line (A549) | Human | CSAG1 | 1:3~1:4 | Negative | Online Inquiry |
CSAG1 Gene Knockout Cell Lines are specialized cellular models where the CSAG1 gene has been genetically inactivated to facilitate the study of its biological functions and mechanisms. This innovative tool is vital for researchers seeking to understand the contributions of CSAG1 to various physiological and pathological processes, including tumorigenesis and immune responses. The knockout mechanism employed leverages advanced CRISPR-Cas9 technology to ensure precise and permanent gene modification, allowing for clear insights into gene function without the confounding effects of the wild-type gene.
The key function of CSAG1 Gene Knockout Cell Lines lies in their ability to mimic specific disease states, making them indispensable in drug discovery and therapeutic research. By elucidating the role of CSAG1 in different cellular contexts, researchers can explore its potential as a biomarker or therapeutic target, enhancing the understanding of complex biological networks involved in diseases such as cancer. Furthermore, these cell lines can be utilized in high-throughput screening assays, enabling the rapid assessment of pharmacological agents affecting CSAG1-related pathways.
Compared to alternative models, CSAG1 Gene Knockout Cell Lines provide unparalleled specificity, as they remove the confounding influence of the CSAG1 gene. Traditional approaches may fall short in delivering the necessary precision, potentially leading to misleading results. These knockout cell lines enable clearer interpretations of therapeutic efficacy and biological relevance, thus optimizing research outcomes.
For researchers and clinicians, the ability to precisely manipulate gene expression is invaluable, driving innovation and discovery in both fundamental biology and clinical applications. The reliable and reproducible nature of our CSAG1 Gene Knockout Cell Lines ensures that users can confidently advance their research agendas, knowing that they are working with a scientifically robust and rigorously validated product.
At our company, expertise in genetic engineering and a commitment to providing top-tier biological products empower us to support researchers in their quests to unlock the mysteries of cellular biology. Our CSAG1 Gene Knockout Cell Lines are a testament to our dedication to advancing scientific understanding and fostering breakthroughs in biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.